{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:59:02Z","timestamp":1773449942625,"version":"3.50.1"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Carpal tunnel syndrome is very common. Although surgery is effective in mild and moderate cases, recovery is often incomplete in severe cases. Therefore, adjuvant therapy to improve nerve regeneration in those patients is much needed. Acetyl-<jats:sc>l<\/jats:sc>-carnitine has been shown to be effective in other neuropathies. The goal of this study is to test the hypothesis that acetyl-<jats:sc>l<\/jats:sc>-carnitine can promote nerve regeneration and improve function in patients with severe carpal tunnel syndrome.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>In this proof-of-principle, double-blind, randomized, placebo-controlled trial, adults with severe carpal tunnel syndrome were randomized to receive 3000 mg\/day of acetyl-<jats:sc>l<\/jats:sc>-carnitine orally or placebo following carpal tunnel release surgery for 2 months. Outcomes were assessed at baseline and at 3, 6, and 12 months postoperatively. Symptom severity and functional outcomes were assessed using the Boston Carpal Tunnel Questionnaire and a wide range of physiologic and functional outcome measures. Patient safety was monitored by physical examination, blood work, and serum drug levels. The outcomes were analyzed using repeated measure two-way analysis of variance.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Twenty patients with similar baseline characteristics were assigned randomly to the treatment or placebo group in a 1:1 ratio. Sixty percent were women with a mean age \u00b1 SD of 59 \u00b1 2. The treatment was safe with no major adverse events reported. Although patients in both groups showed improvements postoperatively, there was no significant difference in any of the outcome measures between the groups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Although acetyl-<jats:sc>l<\/jats:sc>-carnitine was well tolerated, it did not improve nerve regeneration or functional recovery in patients with severe carpal tunnel syndrome.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CLINICAL QUESTION\/LEVEL OF EVIDENCE:<\/jats:title>\n            <jats:p>Therapeutic, II.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/prs.0000000000005089","type":"journal-article","created":{"date-parts":[[2018,12,27]],"date-time":"2018-12-27T19:29:25Z","timestamp":1545938965000},"page":"111e-120e","source":"Crossref","is-referenced-by-count":11,"title":["Acetyl-l-Carnitine to Enhance Nerve Regeneration in Carpal Tunnel Syndrome: A Double-Blind, Randomized, Controlled Trial"],"prefix":"10.1097","volume":"143","author":[{"given":"Matthew W. T.","family":"Curran","sequence":"first","affiliation":[{"name":"From the Department of Surgery, Division of Plastic Surgery, and the Department of Medicine, Division of Physical Medicine and Rehabilitation, University of Alberta; and the Department of Physical Medicine and Rehabilitation, University of Occupational and Environmental Health."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Morhart","sequence":"additional","affiliation":[{"name":"From the Department of Surgery, Division of Plastic Surgery, and the Department of Medicine, Division of Physical Medicine and Rehabilitation, University of Alberta; and the Department of Physical Medicine and Rehabilitation, University of Occupational and Environmental Health."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaret L.","family":"Olson","sequence":"additional","affiliation":[{"name":"From the Department of Surgery, Division of Plastic Surgery, and the Department of Medicine, Division of Physical Medicine and Rehabilitation, University of Alberta; and the Department of Physical Medicine and Rehabilitation, University of Occupational and Environmental Health."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Hachisuka","sequence":"additional","affiliation":[{"name":"From the Department of Surgery, Division of Plastic Surgery, and the Department of Medicine, Division of Physical Medicine and Rehabilitation, University of Alberta; and the Department of Physical Medicine and Rehabilitation, University of Occupational and Environmental Health."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. Ming","family":"Chan","sequence":"additional","affiliation":[{"name":"From the Department of Surgery, Division of Plastic Surgery, and the Department of Medicine, Division of Physical Medicine and Rehabilitation, University of Alberta; and the Department of Physical Medicine and Rehabilitation, University of Occupational and Environmental Health."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20231015","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1001\/jama.282.2.153","article-title":"Prevalence of carpal tunnel syndrome in a general population.","volume":"282","author":"Atroshi","year":"1999","journal-title":"JAMA"},{"key":"R2-20231015","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0363-5023(03)00148-5","article-title":"Severe carpal tunnel syndrome potentially needing surgical treatment in a general population.","volume":"28","author":"Atroshi","year":"2003","journal-title":"J Hand Surg Am"},{"key":"R3-20231015","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1136\/jnnp.74.12.1674","article-title":"Clinical surveillance of carpal tunnel syndrome in two areas of the United Kingdom, 1991-2001.","volume":"74","author":"Bland","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R4-20231015","first-page":"36","article-title":"Carpal tunnel syndrome in general practice (1987 and 2001): Incidence and the role of occupational and non-occupational factors.","volume":"57","author":"Bongers","year":"2007","journal-title":"Br J Gen Pract"},{"key":"R5-20231015","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1097\/00006534-200204150-00013","article-title":"Carpal tunnel release in the United States and Sweden: Reimbursement patterns, cost for treatment, and return to work.","volume":"109","author":"Bitar","year":"2002","journal-title":"Plast Reconstr Surg"},{"key":"R6-20231015","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/(SICI)1097-0274(199803)33:3<197::AID-AJIM1>3.0.CO;2-U","article-title":"Job-related diseases and occupations within a large workers\u2019 compensation data set.","volume":"33","author":"Leigh","year":"1998","journal-title":"Am J Ind Med"},{"key":"R7-20231015","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/ajim.20430","article-title":"The economic burden of carpal tunnel syndrome: Long-term earnings of CTS claimants in Washington State.","volume":"50","author":"Foley","year":"2007","journal-title":"Am J Ind Med"},{"key":"R8-20231015","first-page":"167","article-title":"Social and economic costs of carpal tunnel surgery.","volume":"44","author":"Palmer","year":"1995","journal-title":"Instr Course Lect"},{"key":"R9-20231015","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0749-0712(01)00011-7","article-title":"Surgical release of the carpal tunnel.","volume":"18","author":"Steinberg","year":"2002","journal-title":"Hand Clin"},{"key":"R10-20231015","doi-asserted-by":"crossref","first-page":"7509","DOI":"10.1523\/JNEUROSCI.15-11-07509.1995","article-title":"The immunosuppressant FK506 increases the rate of axonal regeneration in rat sciatic nerve.","volume":"15","author":"Gold","year":"1995","journal-title":"J Neurosci"},{"key":"R11-20231015","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000076565","article-title":"FK506 requires stimulation of the extracellular signal-regulated kinase \u00bd and the steroid receptor chaperone protein p23 for neurite elongation.","volume":"13","author":"Gold","year":"2004","journal-title":"Neurosignals"},{"key":"R12-20231015","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/mus.1088","article-title":"Effects of FK506 on nerve regeneration and reinnervation after graft or tube repair of long nerve gaps.","volume":"24","author":"Navarro","year":"2001","journal-title":"Muscle Nerve"},{"key":"R13-20231015","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.neuroscience.2012.07.026","article-title":"Geldanamycin accelerated peripheral nerve regeneration in comparison to FK-506 in vivo.","volume":"223","author":"Sun","year":"2012","journal-title":"Neuroscience"},{"key":"R14-20231015","first-page":"185","article-title":"Ultrastructural aspects of ageing rat hippocampus and effects of L-acetyl-carnitine treatment.","volume":"13","author":"Badiali de Giorgi","year":"1987","journal-title":"Drugs Exp Clin Res"},{"key":"R15-20231015","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0167-4943(89)90071-X","article-title":"Age-related changes of the mossy fibre system in rat hippocampus: Effect of long term acetyl-L-carnitine treatment.","volume":"8","author":"Ricci","year":"1989","journal-title":"Arch Gerontol Geriatr"},{"key":"R16-20231015","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2165\/00044011-199815020-00001","article-title":"Tolerability and efficacy of L-acetylcarnitine in patients with peripheral neuropathies: A short-term, open multicentre study.","volume":"15","author":"De Grandis","year":"1998","journal-title":"Clin Drug Invest"},{"key":"R17-20231015","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.2106\/00004623-199311000-00002","article-title":"A self-administered questionnaire for the assessment of severity of symptoms and functional status in carpal tunnel syndrome.","volume":"75","author":"Levine","year":"1993","journal-title":"J Bone Joint Surg Am"},{"key":"R18-20231015","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/mus.880160404","article-title":"The estimated numbers and relative sizes of thenar motor units as selected by multiple point stimulation in young and older adults.","volume":"16","author":"Doherty","year":"1993","journal-title":"Muscle Nerve"},{"key":"R19-20231015","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1016\/j.clinph.2008.07.219","article-title":"Test\u2013retest reliability of a modified multiple point stimulation technique for motor unit number estimation.","volume":"119","author":"Porter","year":"2008","journal-title":"Clin Neurophysiol"},{"key":"R20-20231015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1088\/1741-2560\/2\/2\/003","article-title":"Simulations of motor unit number estimation techniques.","volume":"2","author":"Major","year":"2005","journal-title":"J Neural Eng"},{"key":"R21-20231015","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1177\/175899830000500403","article-title":"Comparing the responsiveness over time of two tactile gnosis tests: Two point discrimination and STI-test.","volume":"5","author":"Rosen","year":"2000","journal-title":"Br J Hand Ther"},{"key":"R22-20231015","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0894-1130(12)80314-0","article-title":"Threshold detection and Semmes-Weinstein monofilaments.","volume":"8","author":"Bell-Krotoski","year":"1995","journal-title":"J Hand Ther"},{"key":"R23-20231015","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1682\/JRRD.2011.03.0044","article-title":"Reliability of thermal quantitative sensory testing: A systematic review.","volume":"49","author":"Moloney","year":"2012","journal-title":"J Rehabil Res Dev"},{"key":"R24-20231015","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1212\/WNL.43.8.1508","article-title":"A 4, 2, and 1 stepping algorithm for quick and accurate estimation of cutaneous sensation threshold.","volume":"43","author":"Dyck","year":"1993","journal-title":"Neurology"},{"key":"R25-20231015","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/mus.20750","article-title":"Normative values and the effects of age, gender, and handedness on the Moberg Pick-Up Test.","volume":"35","author":"Amirjani","year":"2007","journal-title":"Muscle Nerve"},{"key":"R26-20231015","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/PRS.0b013e31828bd6ec","article-title":"Minimal clinically important difference of carpal tunnel release in diabetic and nondiabetic patients.","volume":"131","author":"Ozer","year":"2013","journal-title":"Plast Reconstr Surg"},{"key":"R27-20231015","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.3892\/etm.2016.3871","article-title":"A prospective study to evaluate the efficacy and safety of oral acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy.","volume":"12","author":"Sun","year":"2016","journal-title":"Exp Ther Med"},{"key":"R28-20231015","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1016\/j.ejca.2005.04.028","article-title":"Symptomatic and neurophysiological responses of paclitaxel- or cisplatin-induced neuropathy to oral acetyl-L-carnitine.","volume":"41","author":"Bianchi","year":"2005","journal-title":"Eur J Cancer"},{"key":"R29-20231015","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00280-014-2550-5","article-title":"Acetyl-L-carnitine (ALCAR) for the prevention of chemotherapy-induced peripheral neuropathy in patients with relapsed or refractory multiple myeloma treated with bortezomib, doxorubicin and low-dose dexamethasone: A study from the Wisconsin Oncology Network.","volume":"74","author":"Callander","year":"2014","journal-title":"Cancer Chemother Pharmacol"},{"key":"R30-20231015","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.bjps.2003.08.005","article-title":"Primary sensory neuronal rescue with systemic acetyl-L-carnitine following peripheral axotomy: A dose-response analysis.","volume":"56","author":"Wilson","year":"2003","journal-title":"Br J Plast Surg"},{"key":"R31-20231015","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1002\/1529-0131(200105)44:5<1184::AID-ANR202>3.0.CO;2-A","article-title":"Predictors of outcomes of carpal tunnel release.","volume":"44","author":"Katz","year":"2001","journal-title":"Arthritis Rheum"},{"key":"R32-20231015","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s00776-004-0852-x","article-title":"Clinical results in severe carpal tunnel syndrome and motor nerve conduction studies.","volume":"10","author":"Nobuta","year":"2005","journal-title":"J Orthop Sci"},{"key":"R33-20231015","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.clinph.2010.03.014","article-title":"Neurophysiologic recovery after carpal tunnel release in diabetic patients.","volume":"121","author":"Thomsen","year":"2010","journal-title":"Clin Neurophysiol"},{"key":"R34-20231015","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/2000656X.2016.1210521","article-title":"Outcome after carpal tunnel release: Impact of factors related to metabolic syndrome.","volume":"51","author":"Zimmerman","year":"2017","journal-title":"J Plast Surg Hand Surg"},{"key":"R35-20231015","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2337\/diacare.28.1.89","article-title":"Acetyl-L-carnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy: An analysis of two randomized placebo-controlled trials.","volume":"28","author":"Sima","year":"2005","journal-title":"Diabetes Care"},{"key":"R36-20231015","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2165\/00126839-200203040-00001","article-title":"Acetyl-L-carnitine (levacecarnine) in the treatment of diabetic neuropathy: A long-term, randomised, double-blind, placebo-controlled study.","volume":"3","author":"De Grandis","year":"2002","journal-title":"Drugs R D"},{"key":"R37-20231015","first-page":"67","article-title":"Neuroprotective effects of acetyl-L-carnitine in experimental chronic compression neuropathy: A prospective, randomized and placebo-control trials.","volume":"17","author":"Kotil","year":"2007","journal-title":"Turk Neurosurg"},{"key":"R38-20231015","first-page":"CD001552","article-title":"Surgical versus non-surgical treatment for carpal tunnel syndrome.","volume":"4","author":"Verdugo","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"R39-20231015","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1126\/science.286.5443.1358","article-title":"Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms.","volume":"286","author":"Bonni","year":"1999","journal-title":"Science"},{"key":"R40-20231015","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2202-12-12","article-title":"Axonal outgrowth is associated with increased ERK 1\/2 activation but decreased caspase 3 linked cell death in Schwann cells after immediate nerve repair in rats.","volume":"12","author":"Tsuda","year":"2011","journal-title":"BMC Neurosci"},{"key":"R41-20231015","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1126\/science.286.5448.2358","article-title":"Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons.","volume":"286","author":"Riccio","year":"1999","journal-title":"Science"},{"key":"R42-20231015","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.neuroscience.2010.09.036","article-title":"Methylcobalamin, but not methylprednisolone or pleiotrophin, accelerates the recovery of rat biceps after ulnar to musculocutaneous nerve transfer.","volume":"171","author":"Liao","year":"2010","journal-title":"Neuroscience"},{"key":"R43-20231015","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.expneurol.2009.12.017","article-title":"Methylcobalamin increases Erk1\/2 and Akt activities through the methylation cycle and promotes nerve regeneration in a rat sciatic nerve injury model.","volume":"222","author":"Okada","year":"2010","journal-title":"Exp Neurol"},{"key":"R44-20231015","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1177\/1753193411427826","article-title":"Tolerance and effects of FK506 (tacrolimus) on nerve regeneration: A pilot study.","volume":"37","author":"Phan","year":"2012","journal-title":"J Hand Surg Eur Vol"},{"key":"R45-20231015","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s10571-015-0193-7","article-title":"Liraglutide promotes cortical neurite outgrowth via the MEK-ERK pathway.","volume":"35","author":"Li","year":"2015","journal-title":"Cell Mol Neurobiol"}],"container-title":["Plastic &amp; Reconstructive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006534-201901000-00032","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T05:14:19Z","timestamp":1697346859000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006534-201901000-00032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/prs.0000000000005089","relation":{},"ISSN":["0032-1052"],"issn-type":[{"value":"0032-1052","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]}}}